التفاصيل البيبلوغرافية
| العنوان: |
Laboratory Assessment of Novel Oral Anticoagulants: Method Suitability and Variability between Coagulation Laboratories |
| المؤلفون: |
Helin, Tuukka A., Pakkanen, Anja, Lassila, Riitta, Joutsi-Korhonen, Lotta |
| المساهمون: |
Medicum, Department of Clinical Chemistry and Hematology, Clinicum, Department of Diagnostics and Therapeutics, Hematologian yksikkö |
| بيانات النشر: |
American Association for Clinical Chemistry |
| سنة النشر: |
2023 |
| المجموعة: |
Helsingfors Universitet: HELDA – Helsingin yliopiston digitaalinen arkisto |
| مصطلحات موضوعية: |
DIRECT THROMBIN INHIBITOR, NONVALVULAR ATRIAL-FIBRILLATION, FACTOR XA INHIBITOR, DABIGATRAN ETEXILATE, PROTHROMBIN TIME, STROKE PREVENTION, IN-VITRO, RIVAROXABAN, ASSAYS, REVERSAL, 3141 Health care science, 3121 General medicine, internal medicine and other clinical medicine |
| الوصف: |
Peer reviewed |
| نوع الوثيقة: |
article in journal/newspaper |
| وصف الملف: |
application/pdf |
| اللغة: |
English |
| العلاقة: |
Boehringer Ingelheim Finland and Bayer Schering Pharma Finland (study samples).; Helin , T A , Pakkanen , A , Lassila , R & Joutsi-Korhonen , L 2013 , ' Laboratory Assessment of Novel Oral Anticoagulants: Method Suitability and Variability between Coagulation Laboratories ' , Clinical Chemistry (Washington, DC) , vol. 59 , no. 5 , pp. 807-814 . https://doi.org/10.1373/clinchem.2012.198788Test; ORCID: /0000-0002-5273-8088/work/150714093; 84876943998; 44887c06-ea3e-4b6d-b3c6-d52e530ad24e; http://hdl.handle.net/10138/567611Test; 000321547700016 |
| الإتاحة: |
http://hdl.handle.net/10138/567611Test |
| حقوق: |
openAccess ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: |
edsbas.42238C62 |
| قاعدة البيانات: |
BASE |
